Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term, Open-Label, Extension Study to Evaluate the Safety and Efficacy of Tapinarof Cream, 1% for the Treatment of Plaque Psoriasis in Adults

NCT04053387 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT04053387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04053387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term, Open-Label, Extension Study to Evaluate the Safety and Efficacy of Tapinarof Cream, 1% for the Treatment of Plaque Psoriasis in Adults
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
August 13, 2019
Completion date
April 6, 2021
Enrollment
763 (actual)
Sites
104

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis